Skip to content

Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study

Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06948565
Acronym
REACIRRHOSE
Enrollment
500
Registered
2025-04-29
Start date
2025-08-08
Completion date
2026-12-31
Last updated
2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute on Chronic Liver Failure(ACLF), Cirrhosis, Intensive Care Medicine

Keywords

prognosis, cirrhosis, ICU, ACLF

Brief summary

Ten years after our team's publication, practices have changed considerably in the management of severe cirrhotic patients. This study will analyse these practices in primary care hospitals and in a tertiary centre, and assess the impact of these changes on the prognosis of these patients. The following hypotheses will be tested: * Improvement in intensive care and overall prognosis compared with data from the literature prior to 2014 * Improved access to liver transplantation compared with the literature prior to 2014 * Improvement in intensive care unit practices (for example: application of recommendations published by learned societies concerning the intensive care unit management of patients with cirrhosis, access to comfort care, degree of clinical severity on admission to the intensive care unit, etc.). * Centre' effect: variability in the phenotype of patients admitted to intensive care depending on the technical facilities available and whether or not the hospital centre has access to TH.

Interventions

OTHERobservational study

This observational study aims to describe the clinical practices and the outcome of patients admitted in ICU.

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Patients with cirrhosis over 18 years of age (cirrhosis either histologically proven or diagnosed by hepatologists according to clinical, biological and ultrasound criteria) admitted to intensive care between January 2014 and December 2024.

Exclusion criteria

None

Design outcomes

Primary

MeasureTime frame
28-day survival28 days

Secondary

MeasureTime frame
Overall survivalthrough study completion
Survival without liver transplantation12 months
Proportion of patients listed for liver transplantationthrough study completion
Phenotype of patients admitted to intensive carebaseline
Prognostic performance of general and cirrhosis-specific organ failure scoresbaseline
Comparison of the characteristics of patients on admission in primary care hospitals and in university hospital.baseline
number of patients receiving LTthrough study completion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026